{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:10:55Z","timestamp":1791443455584,"version":"4.3.3"},"reference-count":158,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["786142"],"award-info":[{"award-number":["786142"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.kint.2022.02.031","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:59:46Z","timestamp":1648069186000},"page":"1142-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Type I interferon\u2013related kidney disorders"],"prefix":"10.1016","volume":"101","author":[{"given":"Lorenzo","family":"Lodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Mastrolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Angelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanick J.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-8088","authenticated-orcid":false,"given":"Paola","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-9172","authenticated-orcid":false,"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2022.02.031_bib1","doi-asserted-by":"crossref","first-page":"633821","DOI":"10.3389\/fphar.2021.633821","article-title":"Type I interferons in systemic autoimmune diseases: distinguishing between afferent and efferent functions for precision medicine and individualized treatment","volume":"12","author":"Chasset","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.kint.2022.02.031_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.ajkd.2019.07.010","article-title":"APOL1-associated collapsing focal segmental glomerulosclerosis in a patient with stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI)","volume":"75","author":"Abid","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1053\/j.ajkd.2021.02.330","article-title":"Collapsing glomerulopathy as a complication of type I\u2013interferon-mediated glomerulopathy in a patient with RNASEH2B-related Aicardi-Gouti\u00e8res syndrome","volume":"78","author":"Fenaroli","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib6","first-page":"109","article-title":"Broad spectrum of interferon-related nephropathies\u2014glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: a case report and review of literature","volume":"8","author":"Gianassi","year":"2019","journal-title":"World J Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.kint.2022.02.031_bib8","first-page":"1700","article-title":"[Immunizing property of vaccinia virus inactivated by ultraviolets rays]","volume":"148","author":"Nagano","year":"1954","journal-title":"C\u00a0R Seances Soc Biol Fil"},{"key":"10.1016\/j.kint.2022.02.031_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.kint.2022.02.031_bib11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2005.06.009","article-title":"TLR signalling and activation of IRFs: revisiting old friends from the NF-\u03baB pathway","volume":"26","author":"Moynagh","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","article-title":"Cytosolic sensing of viruses","volume":"38","author":"Goubau","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2022.02.031_bib15","first-page":"e23820","article-title":"The regulation of inflammation by interferons and their STATs","volume":"2","author":"Rauch","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.kint.2022.02.031_bib16","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type I interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.kint.2022.02.031_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cyto.2011.07.019","article-title":"Binding and activity of all human alpha interferon subtypes","volume":"56","author":"Lavoie","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.kint.2022.02.031_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41423-019-0343-9","article-title":"Plasmacytoid dendritic cells promote acute kidney injury by producing interferon-\u03b1","volume":"18","author":"Deng","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib19","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1128\/JVI.00196-08","article-title":"CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells","volume":"82","author":"Haupt","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.kint.2022.02.031_bib20","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.4049\/jimmunol.0900742","article-title":"Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis","volume":"183","author":"Fairhurst","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000489507","article-title":"Toll-like receptor 3 signaling contributes to regional neutrophil recruitment in cultured human glomerular endothelial cells","volume":"139","author":"Liu","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2022.02.031_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/14397595.2019.1682768","article-title":"Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells","volume":"30","author":"Hirono","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib23","doi-asserted-by":"crossref","first-page":"15485","DOI":"10.1038\/s41598-019-51998-w","article-title":"Nucleosomal dsDNA stimulates APOL1 expression in human cultured podocytes by activating the cGAS\/IFI16-STING signaling pathway","volume":"9","author":"Davis","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2022.02.031_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00109-020-01879-x","article-title":"RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice","volume":"98","author":"Zhou","year":"2020","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.kint.2022.02.031_bib25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2010.71","article-title":"Interferon-\u03b1 and -\u03b2 in kidney inflammation","volume":"77","author":"Anders","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.02.031_bib26","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2005.01.005","article-title":"Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling","volume":"22","author":"Hahm","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2022.02.031_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ni1136","article-title":"Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection","volume":"5","author":"Zuniga","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.1005201108","article-title":"Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue","volume":"108","author":"Iijima","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2022.02.031_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2022.02.031_bib31","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1681\/ASN.2008040394","article-title":"Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression","volume":"19","author":"Datta","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib32","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.0914902107","article-title":"Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages","volume":"107","author":"Triantafyllopoulou","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2022.02.031_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-018-1568-1","article-title":"Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons","volume":"20","author":"Kishimoto","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2022.02.031_bib34","doi-asserted-by":"crossref","first-page":"151491","DOI":"10.1016\/j.ijmm.2021.151491","article-title":"Interferons at the crossroad of cell death pathways during gastrointestinal inflammation and infection","volume":"311","author":"Stolzer","year":"2021","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.kint.2022.02.031_bib35","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/rheumatology\/keu249","article-title":"Interferon-\u03b1-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erythematosus monocytes","volume":"53","author":"Lopez","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2022.02.031_bib36","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.4049\/jimmunol.1800393","article-title":"Integrated B cell, Toll-like, and BAFF receptor signals promote autoantibody production by transitional B cells","volume":"201","author":"Du","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib37","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00296-019-04426-1","article-title":"Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus","volume":"39","author":"Jeremic","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2022.02.031_bib38","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1700778","article-title":"Netting neutrophils activate autoreactive B cells in lupus","volume":"200","author":"Gestermann","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib39","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-\u03b1 on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib40","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ki.2008.308","article-title":"Increased glomerular matrix metalloproteinase activity in murine lupus nephritis","volume":"74","author":"Tveita","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.02.031_bib41","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms19092532","article-title":"Targeting TGF-\u03b2 signaling in kidney fibrosis","volume":"19","author":"Isaka","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2022.02.031_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.phrs.2012.09.006","article-title":"The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling","volume":"66","author":"Paccosi","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.kint.2022.02.031_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2022.02.031_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajpath.2013.04.017","article-title":"The antiviral cytokines IFN-\u03b1 and IFN-\u03b2 modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration","volume":"183","author":"Migliorini","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2022.02.031_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/156652413804486250","article-title":"Podocyte mitosis\u2014a catastrophe","volume":"13","author":"Lasagni","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.kint.2022.02.031_bib46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-\u03b1 in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fonc.2017.00051","article-title":"Autophagy and the cell cycle: a complex landscape","volume":"7","author":"Mathiassen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.kint.2022.02.031_bib48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrneph.2014.184","article-title":"Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease","volume":"10","author":"Kok","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib49","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/MCB.26.5.1888-1897.2006","article-title":"Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta","volume":"26","author":"Jaitin","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2022.02.031_bib50","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1189\/jlb.1205742","article-title":"Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression","volume":"79","author":"Severa","year":"2006","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.kint.2022.02.031_bib51","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1074\/jbc.R116.774562","article-title":"The molecular basis for differential type I interferon signaling","volume":"292","author":"Schreiber","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2022.02.031_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"issue":"suppl 118","key":"10.1016\/j.kint.2022.02.031_bib54","first-page":"185","article-title":"Type I interferon signature in Sj\u00f6gren\u2019s syndrome: pathophysiological and clinical implications","volume":"37","author":"Marketos","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.kint.2022.02.031_bib56","first-page":"1","article-title":"The type I interferonopathies: 10 years on","volume":"20","author":"Crow","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-042718-041257","article-title":"Self-awareness: nucleic acid-driven inflammation and the type I interferonopathies","volume":"37","author":"Uggenti","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10875-020-00952-x","article-title":"Differential expression of interferon-alpha protein provides clues to tissue specificity across type I interferonopathies","volume":"41","author":"Lodi","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib59","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ekir.2019.04.014","article-title":"COPA syndrome as a cause of lupus nephritis","volume":"4","author":"Boulisfane-El Khalifi","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2022.02.031_bib60","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib61","doi-asserted-by":"crossref","first-page":"104262","DOI":"10.1016\/j.ejmg.2021.104262","article-title":"Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis","volume":"64","author":"Kisla Ekinci","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib62","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2022.02.031_bib63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0961203316629000","article-title":"Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature","volume":"25","author":"Bilginer","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2022.02.031_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12098-020-03636-x","article-title":"Monogenic lupus with IgA nephropathy caused by spondyloenchondrodysplasia with immune dysregulation","volume":"88","author":"Sait","year":"2021","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.kint.2022.02.031_bib65","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fimmu.2020.00985","article-title":"Interstitial lung disease and psoriasis in a child with Aicardi-Goutieres syndrome","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib67","doi-asserted-by":"crossref","first-page":"00017","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.kint.2022.02.031_bib68","first-page":"3624795","article-title":"Lung transplantation in a patient with COPA syndrome","volume":"2020","author":"Mallea","year":"2020","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.kint.2022.02.031_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-021-00497-2","article-title":"Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect","volume":"19","author":"He","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2022.02.031_bib70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.a.31526","article-title":"A\u00a0syndrome of immunodeficiency, autoimmunity, and spondylometaphyseal dysplasia","volume":"143A","author":"Kulkarni","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.kint.2022.02.031_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib72","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12969-015-0035-7","article-title":"Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene","volume":"13","author":"Girschick","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2022.02.031_bib74","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00296-020-04653-x","article-title":"Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review","volume":"40","author":"Kara","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2022.02.031_bib75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10875-019-00645-0","article-title":"Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome","volume":"39","author":"Volpi","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib76","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10875-020-00850-2","article-title":"Case report: acute thrombotic microangiopathy in a patient with STING-associated vasculopathy with onset in infancy (SAVI)","volume":"40","author":"Ma","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib77","doi-asserted-by":"crossref","first-page":"575219","DOI":"10.3389\/fimmu.2020.575219","article-title":"Adult-onset ANCA-associated vasculitis in SAVI: extension of the phenotypic spectrum, case report and review of the literature","volume":"11","author":"Staels","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib78","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients","volume":"9","author":"Fr\u00e9mond","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.kint.2022.02.031_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib80","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib81","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3899\/jrheum.150024","article-title":"A\u00a0case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations","volume":"42","author":"Batu","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib82","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0948","article-title":"Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with canakinumab","volume":"142","author":"Kisla Ekinci","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.kint.2022.02.031_bib83","doi-asserted-by":"crossref","first-page":"eaav7501","DOI":"10.1126\/sciimmunol.aav7501","article-title":"Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2","volume":"4","author":"Duncan","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib84","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib85","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.38010","article-title":"DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome","volume":"65","author":"Oz\u00e7akar","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2022.02.031_bib86","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0961203316676382","article-title":"An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus","volume":"26","author":"Carbonella","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2022.02.031_bib87","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3899\/jrheum.171358","article-title":"Whole exome sequencing in early-onset systemic lupus erythematosus","volume":"45","author":"Batu","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib88","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1016\/S2665-9913(19)30142-0","article-title":"Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts","volume":"2","author":"Belot","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib89","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201138","article-title":"Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus","volume":"218","author":"Hartl","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2022.02.031_bib90","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.41790","article-title":"Augmentation of STING-induced type I interferon production in COPA syndrome","volume":"73","author":"Kato","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib92","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with a neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2022.02.031_bib93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","volume":"14","author":"Caorsi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2022.02.031_bib94","doi-asserted-by":"crossref","unstructured":"Greiner-Tollersrud OK, Boehler V, Bartok E, et\u00a0al. ADA2 is a lysosomal DNase regulating the type-I interferon response. bioR\u03c7iv. Published online June 22, 2020. https:\/\/doi.org\/10.1101\/2020.06.21.162990","DOI":"10.1101\/2020.06.21.162990"},{"key":"10.1016\/j.kint.2022.02.031_bib95","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib96","first-page":"712","article-title":"New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond","volume":"9","author":"Demirkaya","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.kint.2022.02.031_bib97","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1002\/art.20721","article-title":"Novel DNASE I mutations related to systemic lupus erythematosus","volume":"50","author":"Bodano","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2022.02.031_bib98","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u02b9-5\u02b9 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib99","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajhg.2014.11.019","article-title":"Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome","volume":"96","author":"Jang","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2022.02.031_bib101","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2021.03.045","article-title":"Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency","volume":"148","author":"Vavassori","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib102","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib103","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib104","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/art.23613","article-title":"Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients","volume":"58","author":"Niewold","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2022.02.031_bib105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000087","article-title":"Advances in understanding the role of type I interferons in systemic lupus erythematosus","volume":"26","author":"Crow","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis","volume":"47","author":"Bruschi","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib107","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2022.02.031_bib108","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2022.02.031_bib109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib111","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2018.03.016","article-title":"Drug-induced lupus: traditional and new concepts","volume":"17","author":"Vaglio","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2022.02.031_bib112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib113","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2215\/CJN.06720615","article-title":"Clinical-morphological features and outcomes of lupus podocytopathy","volume":"11","author":"Hu","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib114","doi-asserted-by":"crossref","first-page":"676082","DOI":"10.3389\/fimmu.2021.676082","article-title":"IFN-I mediates lupus nephritis from the beginning to renal fibrosis","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14397595.2017.1404711","article-title":"Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-na\u00efve lupus nephritis, but not in those under immunosuppressive treatment","volume":"28","author":"Shimizu","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib116","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib117","doi-asserted-by":"crossref","first-page":"e93009","DOI":"10.1172\/jci.insight.93009","article-title":"Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis","volume":"2","author":"Der","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2022.02.031_bib118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(88)90125-6","article-title":"Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy","volume":"84","author":"Lebon","year":"1988","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.kint.2022.02.031_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ckj\/sft002","article-title":"Viruses and collapsing glomerulopathy: a brief critical review","volume":"6","author":"Chandra","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2022.02.031_bib120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ndt\/18.2.285","article-title":"Upregulation of MHC class II, interferon-\u03b1 and interferon-\u03b3 receptor protein expression in HIV-associated nephropathy","volume":"18","author":"Kimmel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2022.02.031_bib121","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2022.02.031_bib122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-016-0330-7","article-title":"Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation","volume":"17","author":"Besse","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib123","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1111\/febs.15677","article-title":"APOL1 risk variants and the development of HIV-associated nephropathy","volume":"288","author":"Goyal","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.kint.2022.02.031_bib124","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ekir.2020.05.005","article-title":"Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against \u201cSARS-CoV-2 nephropathy.\u201d","volume":"5","author":"Rossi","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2022.02.031_bib126","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.kint.2021.07.015","article-title":"A\u00a0multi-center retrospective cohort study defines the spectrum of kidney pathology in coronavirus 2019 disease (COVID-19)","volume":"100","author":"May","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.02.031_bib127","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2022.02.031_bib128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2018.05.008","article-title":"Donor\u2019s APOL1 risk genotype and \u201csecond hits\u201d associated with de novo collapsing glomerulopathy in deceased donor kidney transplant recipients: a report of 5 cases","volume":"73","author":"Chang","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.semnephrol.2008.08.010","article-title":"Viruses and kidney disease: beyond HIV","volume":"28","author":"Waldman","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-3062.2010.00512.x","article-title":"Increased viral load after intravenous immunoglobulin therapy for BK virus-associated nephropathy","volume":"12","author":"Maggiore","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib131","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1, -\u03b2, or -\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib132","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0961203314523871","article-title":"Drug-induced lupus: including anti-tumour necrosis factor and interferon induced","volume":"23","author":"Araujo-Fernandez","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2022.02.031_bib133","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ckj\/sfw143","article-title":"Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab","volume":"10","author":"Allinovi","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2022.02.031_bib134","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12325-015-0212-6","article-title":"Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon \u03b2-1a","volume":"32","author":"Ben-Amor","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.kint.2022.02.031_bib135","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.kint.2022.02.031_bib136","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2009020132","article-title":"Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis","volume":"20","author":"Smeets","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib137","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1681\/ASN.2009010122","article-title":"Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells","volume":"20","author":"Smeets","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib138","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12882-020-01911-9","article-title":"Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy","volume":"21","author":"Kauffmann","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib139","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ekir.2017.04.008","article-title":"Effect of thrombotic microangiopathy on clinical outcomes in Indian patients with lupus nephritis","volume":"2","author":"Pattanashetti","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2022.02.031_bib140","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib141","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon \u03b1 protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2022.02.031_bib142","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.40792","article-title":"Monitoring disease activity in systemic lupus erythematosus with single-molecule array digital enzyme-linked immunosorbent assay quantification of serum interferon-\u03b1","volume":"71","author":"Mathian","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib143","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-med-050715-104506","article-title":"The type I interferonopathies","volume":"68","author":"Lee-Kirsch","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.kint.2022.02.031_bib144","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semnephrol.2017.07.009","article-title":"Clinical genetic testing for APOL1: are we there yet?","volume":"37","author":"Young","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2022.02.031_bib145","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/MCB.00146-10","article-title":"The type I interferon signaling pathway is a target for glucocorticoid inhibition","volume":"30","author":"Flammer","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2022.02.031_bib146","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.1017296108","article-title":"Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation","volume":"108","author":"Bhattacharyya","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2022.02.031_bib147","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","article-title":"Type I interferonopathies in pediatric rheumatology","volume":"14","author":"Volpi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.kint.2022.02.031_bib148","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib149","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMc1810983","article-title":"Reverse-transcriptase inhibitors in the Aicardi-Goutieres syndrome","volume":"379","author":"Rice","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.kint.2022.02.031_bib151","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2022.02.031_bib152","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib153","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jaci.2016.10.030","article-title":"Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173","volume":"139","author":"Seo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib154","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the Aicardi-Gouti\u00e8res syndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2022.02.031_bib155","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2022.02.031_bib156","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2022.02.031_bib157","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/art.40805","article-title":"Efficacy of baricitinib in the treatment of chilblains associated with Aicardi-Gouti\u00e8res syndrome, a type I interferonopathy","volume":"71","author":"Meesilpavikkai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2022.02.031_bib158","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Wallace","year":"2018","journal-title":"Lancet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822002137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253822002137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:41:31Z","timestamp":1780281691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253822002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0085253822002137"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2022.02.031","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferon\u2013related kidney disorders","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2022.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}